concept

DOPAMINERGIC NEURODEGENERATION

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about DOPAMINERGIC NEURODEGENERATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

47Connections

0Hypotheses

4Analyses

0Outgoing

47Incoming

0Experiments

6Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	DOPAMINERGIC NEURODEGENERATION

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Dopaminergic Neurodegeneration

mechanism · 1969 words

→

Pathway Diagram

graph TD
    DOPAMINERGIC_NEURODEGENERATION["DOPAMINERGIC NEURODEGENERATION"]
    STING["STING"] -->|"mediates"| DOPAMINERGIC_NEURODEGENERATION
    Parkinson_s_Disease["Parkinson's Disease"] -->|"causes"| DOPAMINERGIC_NEURODEGENERATION
    CD4_Deletion["CD4 Deletion"] -.protects against.-> DOPAMINERGIC_NEURODEGENERATION
    RGS6["RGS6"] -.protects against.-> DOPAMINERGIC_NEURODEGENERATION
    GM1_Ganglioside["GM1 Ganglioside"] -->|"mediates"| DOPAMINERGIC_NEURODEGENERATION
    MCH_Neuronal_Projections_to_Su["MCH Neuronal Projections to Substantia Nigra"] -.protects against.-> DOPAMINERGIC_NEURODEGENERATION

Outgoing (0)

Target	Relation	Type	Str
No outgoing edges

Incoming (47)

Source	Relation	Type	Str
LNK	regulates	gene	0.95
M6A Hypomethylation	causes	biomarker	0.95
STING	mediates	entity	0.95
Ferroptosis	mediates	process	0.95
Parkinson's Disease	causes	disease	0.95
Age	associated_with	process	0.95
STING	mediates	protein	0.95
Alpha-Synuclein	associated_with	protein	0.93
CD4 Deletion	protects_against	mechanism	0.90
RIP3	suppresses	protein	0.90
Ferroptosis	contributes_to	process	0.90
Inflammasome	mediates	pathway	0.90
STING	contributes_to	protein	0.90
RGS6	causes	gene	0.90
LEPTIN	protects_against	protein	0.90
G2019S LRRK2	contributes_to	protein	0.90
Lifitegrast	treats	drug	0.90
substantia nigra pars compacta	associated_with	brain_region	0.90
m6A methylation	suppresses	process	0.90
A1 astrocyte conversion	promotes	process	0.88
neuroinflammation	contributes_to	process	0.88
SR9009	protects_against	drug	0.87
lifitegrast	treats	drug	0.87
Mch Projections	protects_against	pathway	0.85
TAL1	contributes_to	enzyme	0.85
Astrocyte Dysfunction	associated_with	process	0.85
Intrinsic Apoptosis	contributes_to	pathway	0.85
URG7	protects_against	protein	0.85
RGS6	protects_against	gene	0.85
SNCA	causes	gene	0.85
LAG3	contributes_to	gene	0.85
APLP1	contributes_to	gene	0.85
MCH Neuronal Projections to Substantia Nigra	protects_against	pathway	0.85
GM1 Ganglioside	mediates	compound	0.85
lifitegrast	protects_against	drug	0.80
lifitegrast	associated_with	drug	0.80
NLRP3	mediates	gene	0.80
SNCA	associated_with	gene	0.80
STING1	activates	protein	0.70
STING ablation	protects_against	process	0.70
STING	activates	protein	0.70
TAL1	activates	protein	0.70
cGAS-STING pathway	activates	pathway	0.70
NLRP3 inflammasome activation	contributes to	mechanism	0.70
alpha-synuclein pathology	causes	phenotype	0.70
Neuroinflammatory Priming	associated_with	phenotype	0.70
MPTP	activates	drug	0.70